I believe the 3 numbers in your screen name tell us all we need to know about your intentions. 666 is so cutting edge in a 1980s high school king of way. Do you still have your uber cool Goth cloths in the closet?
This stupid board does not permit links.
neutrolintm, a catheter lock solution (cls) with no reported human resistance, significantly reduces the rates of infection and thrombosis in hemodialysis patients enrolled in a post-approval surveillance study
I believe the judge is telling the kids "Go back home and work it out so I don't have to pen a big, fat opinion." Interesting to see if Tauropharm comes to the table or chooses to take their chances with whatever entity gobbles up CRMD. Data set on Sat was robust/compelling.
I remain hopeful that good news on Friday will shift the momentum back in the Bulls' favor. Of course a buyout announcement at a handsome premium would do the same!
The Switch is the Key. It will buy ZIOP Time and generate $$$$ to develop other indications on their own.
Yeah---sure----on 8 million shares. You need to get a new day job. Your short paymasters will soon be unable to compensate you your daily gruel. Wait until Monday's XON CC. More fun in store.
Pigs are very, very smart. Far smarter than most breeds of dog. Truffle pigs are very good at finding things of value buried in the litter. I will put Elliot/Evercore against TruthSweeper any day of the week. The truth wins out in the end. You really should take a look @ the NUMP data set. It is pretty near astounding and far surpasses the PHIII bar. . I would not be surprised if posters re: same show up at medical conferences in the coming months. The data set is that good.....
These guys are not short, they are simply seeking to scoop up cheap shares. No professional short would get between ELLIOT and a deal especially after a world class banker is brought in to "explore strategic options". Scuttlebutt says the Saturday presentation went VERY well. This is sold before April is out.
You are either misinformed or simply trying to cast doubt . The presentation was selected by NKF and given by a well respected German professor. Data set was new and VERY solid AND well in excess of what is needed for level III bar. Please try to get your facts right the next time you are seeking to "inform" the masses.
More presentations likely coming as NUMP program accrues patient data.
Settle now or deal with CRMD's partner/acquirer. The BIG BOYS will take no prisoners. Elliot will add their immense weight to the festivities. CLOCK IS TICKING......
I think I see some flatbeds pulling up.
Right, Kirk's Tanks are cresting the hill right now preparing to roll over the shorts. Are they called shorts based upon some anatomical feature?
Options Expiry today. Lots of 10s and 11s O/S. They will let this breath next week.
I continue to believe that partnering talks likely morph into buyout discussions. QIDP (10 years exclusivity in the US) , the EU lawsuit(s) plus the accrued tax losses make this too sweet of a prize to pass up. We will be waving bye by April.
Becton, ABT, BAX on the supply front. Any number of companies from Amgen to KERX in the drug space. This is a catheter care product NOT simply a dialysis bet so I doubt DaVita of Fresenius.
I guess fuel oil and fertilizer should be banned as well. Bas --not to mention box cutters. You are silly.
This is not a management problem. Nothing can be done about the general level of metals pricing. If all in costs(labor, materials, energy etc.) are X and selling price for output is below X they are stuck for the foreseeable future. At least management is trying to get its balance sheet back into some semblance of order. The financings of the last few years would have made sense if metals prices stayed up. In hindsight , it was a steep price to pay to develop Milligan.